Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 1, 2013, Pages 39-40

  Gangemi, Sebastiano ^a,b   Allegra, Alessandro ^a   Alonci, Andrea ^a   Pace, Elisabetta ^b   Cannavò, Antonino ^a   Ferraro, Maria ^b   Penna, Giuseppa ^a   Saitta, Salvatore ^a   Gerace, Demetrio ^a   Musolino, Caterina ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD38 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 23; PROTEIN KINASE ZAP 70; STAT3 PROTEIN;

AGED; ANTIGEN EXPRESSION; B CELL LEUKEMIA; CARBOXY TERMINAL SEQUENCE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; LETTER; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD38; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84869889790     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.07.002     Document Type: Letter

References (8)

1. McCaig A.M., Cosimo E., Leach M.T., Michie A.M. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. Br. J. Haematol. Feb. 24 2011, 10.1111/j.1365-2141.2010.08507.x.
2. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal R., Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
3. Sabat R., Grütz G., Warszawska K., Kirsch S., Witte E., Wolk K., Geginat G. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010, 21:331-344.
4. Brunsing R.L., Prossnitz E.R. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology Jul. 2 2011, [Epub ahead of print]. 10.1111/j.1365-2567.2011.03471.x.
5. Knauf W.U., Ehlers B., Bisson S., Thiel E. Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia. Blood 1995, 88:4382-4383.
6. Deaglio S., Vaisitti T., Serra S., Audrito V., Bologna C., D'Arena G., Laurenti L., Gottardi D., Malavasi F. CD38 in chronic lymphocytic leukemia: from bench to bedside?. Mini Rev. Med. Chem. 2011, 11:503-507.
7. Dumoutier L., de Meester C., Tavernier J., Renauld J.C. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J. Biol. Chem. 2009, 284:26377-26384.
8. Gelebart P., Zak Z., Dien-Bard J., Anand M., Lai R. Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl. Oncol. 2011, 1:9-19.